Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
HRP20100282T1 - Farmaceutski pripravak koji sadržava simvastatin i ezetimib - Google Patents
[go: Go Back, main page]

HRP20100282T1 - Farmaceutski pripravak koji sadržava simvastatin i ezetimib - Google Patents

Farmaceutski pripravak koji sadržava simvastatin i ezetimib Download PDF

Info

Publication number
HRP20100282T1
HRP20100282T1 HR20100282T HRP20100282T HRP20100282T1 HR P20100282 T1 HRP20100282 T1 HR P20100282T1 HR 20100282 T HR20100282 T HR 20100282T HR P20100282 T HRP20100282 T HR P20100282T HR P20100282 T1 HRP20100282 T1 HR P20100282T1
Authority
HR
Croatia
Prior art keywords
pharmaceutical preparation
preparation according
contact
reduced
oxygen
Prior art date
Application number
HR20100282T
Other languages
English (en)
Croatian (hr)
Inventor
Kroselj Vesna
Lakse Renata
Toporisic Rebeka
Kastelic Joze
Original Assignee
Krka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34937786&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20100282(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Krka filed Critical Krka
Publication of HRP20100282T1 publication Critical patent/HRP20100282T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dental Preparations (AREA)
  • Adhesives Or Adhesive Processes (AREA)
HR20100282T 2005-07-06 2006-06-30 Farmaceutski pripravak koji sadržava simvastatin i ezetimib HRP20100282T1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05014680A EP1741427A1 (en) 2005-07-06 2005-07-06 Pharmaceutical composition comprising simvastatin and ezetimibe
PCT/EP2006/006369 WO2007003365A1 (en) 2005-07-06 2006-06-30 Pharmaceutical composition comprising simvastatin and ezetimibe

Publications (1)

Publication Number Publication Date
HRP20100282T1 true HRP20100282T1 (hr) 2010-07-31

Family

ID=34937786

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20100282T HRP20100282T1 (hr) 2005-07-06 2006-06-30 Farmaceutski pripravak koji sadržava simvastatin i ezetimib

Country Status (17)

Country Link
US (1) US8921352B2 (sr)
EP (2) EP1741427A1 (sr)
AT (1) ATE464882T1 (sr)
CA (1) CA2614347A1 (sr)
DE (1) DE602006013821D1 (sr)
DK (1) DK1901736T3 (sr)
EA (1) EA013266B1 (sr)
ES (1) ES2341731T3 (sr)
HR (1) HRP20100282T1 (sr)
NO (1) NO340496B1 (sr)
PL (1) PL1901736T3 (sr)
PT (1) PT1901736E (sr)
RS (1) RS51338B (sr)
SI (1) SI1901736T1 (sr)
UA (1) UA90521C2 (sr)
WO (1) WO2007003365A1 (sr)
ZA (1) ZA200800111B (sr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0215579D0 (en) 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
ATE485267T1 (de) 2003-12-23 2010-11-15 Astrazeneca Ab Diphenylazetidinonderivate mit die cholesterinabsorption hemmender wirkung
UY29607A1 (es) 2005-06-20 2007-01-31 Astrazeneca Ab Compuestos quimicos
SA06270191B1 (ar) 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
AR057072A1 (es) 2005-06-22 2007-11-14 Astrazeneca Ab Compuestos quimicos derivados de 2-azetidinona, formulacion farmaceutica y un proceso de preparacion del compuesto
TW200811098A (en) 2006-04-27 2008-03-01 Astrazeneca Ab Chemical compounds
WO2008101723A2 (en) * 2007-02-23 2008-08-28 Krka Pharmaceutical composition containing a cholesterol absorption inhibitor
WO2009024889A2 (en) * 2007-08-21 2009-02-26 Ranbaxy Laboratories Limited Pharmaceutical composition comprising a hmg-coa reductase inhibitor and ezetimibe
PL2965752T3 (pl) 2007-12-10 2025-12-08 Assia Chemical Industries Ltd. Formulacja farmaceutyczna zawierająca ezetymib
AU2008337435A1 (en) * 2007-12-17 2009-06-25 Krka, Tovarna Zdravil, D.D., Novo Mesto Suspension comprising non-micronized ezetimibe micro-particles
TR200806302A2 (tr) * 2008-08-22 2010-03-22 Bi̇lgi̇ç Mahmut Çözünürlük ve stabilite artırıcı farmasötik formülasyon.
TR200806300A2 (tr) * 2008-08-22 2010-03-22 B�Lg�� Mahmut Çözünürlük artırıcı farmasötlk formulasyon
MX344885B (es) * 2008-11-10 2017-01-10 Psicofarma S A De C V Proceso para la obtencion de una composicion de rosuvastatina calcica y producto obtenido.
EP2204170A1 (en) * 2008-12-01 2010-07-07 LEK Pharmaceuticals D.D. Pharmaceutical composition comprising ezetimibe and simvastatin
EP2216016A1 (en) * 2009-02-06 2010-08-11 LEK Pharmaceuticals d.d. Process for the preparation of a pharmaceutical composition comprising ezetimibe
WO2011002422A2 (en) * 2009-07-02 2011-01-06 Bilgic Mahmut Solubility enhancing pharmaceutical formulation
WO2011019326A2 (en) * 2009-07-02 2011-02-17 Mahmut Bilgic Solubility and stability enchancing pharmaceutical formulation
WO2011002424A2 (en) 2009-07-02 2011-01-06 Bilgic Mahmut Solubility and stability enchancing pharmaceutical formulation
EP2368543A1 (en) 2010-03-25 2011-09-28 KRKA, tovarna zdravil, d.d., Novo mesto Method of preparing a granulated pharmaceutical composition comprising simvastatin and/or ezetimibe
EP2468258A1 (en) 2010-12-22 2012-06-27 LEK Pharmaceuticals d.d. Process for the preparation of a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient
AR086675A1 (es) * 2011-06-14 2014-01-15 Merck Sharp & Dohme Composiciones farmaceuticas de combinaciones de inhibidores de la dipeptidil peptidasa-4 con simvastatina
CN102266323B (zh) * 2011-08-04 2013-03-27 海南锦瑞制药股份有限公司 依折麦布和辛伐他汀组合物及其制备方法
KR102578578B1 (ko) * 2016-02-03 2023-09-14 삼성전자주식회사 암모니아수 내의 불순물 검출방법
JP7115825B2 (ja) * 2017-06-28 2022-08-09 日医工株式会社 エゼチミブ含有経口製剤及びその製造方法
JP2019014700A (ja) * 2017-07-11 2019-01-31 大原薬品工業株式会社 エゼチミブ含有口腔内崩壊錠及びその製造方法
FR3069545B1 (fr) * 2017-07-27 2020-10-16 Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic Composition d'enrobage exempte de dioxyde de titane
PL425975A1 (pl) * 2018-06-19 2020-01-02 Invest Bielany Spółka Z Ograniczoną Odpowiedzialnością Złożona kompozycja farmaceutyczna do leczenia dyslipidemii i sposób jej wytwarzania
WO2022023206A1 (en) * 2020-07-27 2022-02-03 Krka, D.D., Novo Mesto Bilayer tablet comprising ezetimibe and atorvastatin
CN115227659B (zh) * 2022-08-19 2023-05-02 北京百奥药业有限责任公司 一种依折麦布辛伐他汀组合物及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU548996B2 (en) 1980-02-04 1986-01-09 Merck & Co., Inc. Tetrahydro-2h-pyran-2-one derivatives
US4820850A (en) 1987-07-10 1989-04-11 Merck & Co., Inc. Process for α-C-alkylation of the 8-acyl group on mevinolin and analogs thereof
US4916239A (en) 1988-07-19 1990-04-10 Merck & Co., Inc. Process for the lactonization of mevinic acids and analogs thereof
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US6235311B1 (en) * 1998-03-18 2001-05-22 Bristol-Myers Squibb Company Pharmaceutical composition containing a combination of a statin and aspirin and method
HU230253B1 (hu) * 2001-01-26 2015-11-30 Merck Sharp & Dohme Corp Peroxiszóma proliferátor-aktivált receptor (PPAR) aktivátor(ok) és szterin-abszorpció inhibitor(ok) kombinációi és alkalmazásuk vaszkuláris indikációk kezelésére
EP1241110A1 (en) * 2001-03-16 2002-09-18 Pfizer Products Inc. Dispensing unit for oxygen-sensitive drugs
US6669955B2 (en) * 2001-08-28 2003-12-30 Longwood Pharmaceutical Research, Inc. Combination dosage form containing individual dosage units of a cholesterol-lowering agent, an inhibitor of the renin-angiotensin system, and aspirin
AU2002353659A1 (en) * 2001-12-18 2003-07-15 Synthon B.V. Simvastatin dosage forms
AR040588A1 (es) * 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
SI21400A (sl) * 2003-02-12 2004-08-31 LEK farmacevtska družba d.d. Stabilna farmacevtska oblika z inhibitorjem HMG-CoA reduktaze
WO2005009955A1 (en) 2003-07-31 2005-02-03 Hetero Drugs Limited Ezetimibe polymorphs
WO2005011638A2 (en) * 2003-08-05 2005-02-10 Zentiva, A. S. Methods for the stabilization of atorvastatin
US20060223882A1 (en) * 2005-03-23 2006-10-05 Venkataraman Sundaram Amorphous simvastatin

Also Published As

Publication number Publication date
NO20080627L (no) 2008-04-02
WO2007003365A1 (en) 2007-01-11
EP1901736B1 (en) 2010-04-21
EP1901736A1 (en) 2008-03-26
EA013266B1 (ru) 2010-04-30
RS51338B (sr) 2011-02-28
DK1901736T3 (da) 2010-08-16
UA90521C2 (uk) 2010-05-11
PL1901736T3 (pl) 2010-09-30
ZA200800111B (en) 2008-12-31
PT1901736E (pt) 2010-05-31
ES2341731T3 (es) 2010-06-25
SI1901736T1 (sl) 2010-08-31
DE602006013821D1 (en) 2010-06-02
CA2614347A1 (en) 2007-01-11
EP1741427A1 (en) 2007-01-10
ATE464882T1 (de) 2010-05-15
EA200702416A1 (ru) 2008-04-28
US8921352B2 (en) 2014-12-30
US20080300233A1 (en) 2008-12-04
NO340496B1 (no) 2017-05-02

Similar Documents

Publication Publication Date Title
HRP20100282T1 (hr) Farmaceutski pripravak koji sadržava simvastatin i ezetimib
WO2008014175A3 (en) Granular pharmaceutical compositions
HRP20090194T1 (hr) Suha granulirana kompozicija koja sadrži emtricitabin i tenofovir df
WO2008037716A3 (en) Pharmaceutical compositions comprising nilotinib or its salt
HRP20191104T1 (hr) Pripravci koji sadrže lipofilne aktivne spojeve i postupak za njihovu pripremu
HRP20171784T1 (hr) Kruti farmaceutski pripravak koji sadrži levotiroksin
NO20084065L (no) Hurtig frigivelses paracetamol tabletter
AU2003286994A1 (en) Modified release pharmaceutical composition
AR059852A1 (es) Tabletas de domperidona orodispersables
JP2014169344A (ja) 造粒物の製造法
KR101461841B1 (ko) 의약
CN101584673A (zh) 一种左乙拉西坦片剂及其制备方法
WO2007134158A3 (en) Granules comprising calcium carbonate, a binder and a porosity increasing agent, processes of manufacturing, use in therapy
WO2003026610A3 (en) Process for the preparation of fast dissolving dosage form
TW200640503A (en) Drug formulations having improved pharmacokinetic properties
IS6511A (is) Lyfjaefnablöndur sem innihalda sykurfitusýru estera til að stýra losun á virkum innihaldsefnum
YU34601A (sh) Kompozicije koje sadrže cefuroksim aksetil
NO20081488L (no) Fotostabil farmasoytisk sammensetning inneholdende brivudine til behandling av herpetisk keratitt
NO20083183L (no) Fast farmasoytisk sammensetning inneholdende irbesartan
WO2009135950A3 (en) Process for preparing a tablet containing excipients
WO2004078108A3 (fr) Comprime de fenofibrate et procede de fabrication
JP4593469B2 (ja) 変色改善された５−アミノサリチル酸固形製剤およびその保存方法
RU2015141639A (ru) Комбинированный лекарственный препарат в форме шипучих таблеток и способ его получения
WO2007094883A3 (en) Methods and compositions for improved image quality
JP2016222714A (ja) 医薬